He D, Sha S, Liu X, Yin P, et al. Comparative effectiveness of infliximab vs vedolizumab as first-line biologic therapy in moderate-to-severe ulcerative colitis: A prospective, multicenter, real-world study. Inflamm Bowel Dis 2026 Sep 23:izag185. doi: 10.1093.
PMID: 42777090